Vagal Nerve Stimulator (VNS)

Concepts

• stimulator
• cardiff
• neurosciences department
• vale local health board
• vagal nerve stimulator
• vns therapy
• production of these stimulators
• vns
• monopoly of the global market
• implanted device

Location

University Hospital of Wales, Heath Park, Cardiff CF14 4XW

Description

The Neurosciences department within Cardiff and Vale Local Health Board currently perform Vagal Nerve Stimulator (VNS) therapy. VNS therapy is delivered through an implanted device that sends mild pulses to the vagus nerve at regular intervals throughout the day in an effort to reduce and/or prevent seizures. Patients are referred to this type of therapy when drugs have failed to provide a more manageable treatment. These devices are programmable for a personalised therapy approach and the technology is highly specialised. Currently Livanova hold the monopoly of the global market for VSN products as they hold the patent for the manufacture and production of these stimulators, therefore the Health Board are proposing to award a two year contract.

Total Quantity or Scope

As stated in the description above.

Award Detail

Award Criteria

CPV Codes

• 33158210 - Stimulator

Indicators

• Award on basis of price.

Legal Justification

Livanova hold the patent for VSN products and therefore have a monopoly of the global market. Due to this, the Health Board have no other option than to award a contract direct to Livanova UK Limited as these products are the only items that can reduce and/or prevent seizures for patients.

Other Information

(WA Ref:132472)